Dr. Jimenez is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161
Education & Training
Baylor College of MedicineFellowship, Endocrinology, Diabetes, and Metabolism, 2001 - 2004
University of Miami/Jackson Health SystemResidency, Internal Medicine, 1998 - 2001
Pontifical Xavierian UniversityClass of 1995
Certifications & Licensure
FL State Medical License 2021 - Present
TX State Medical License 2007 - 2027
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- Radioactive Drug (177Lu-DOTATATE) for the Treatment of Locally Advanced, Metastatic, or Unresectable Rare Endocrine Cancers Start of enrollment: 2019 Jun 13
Publications & Presentations
PubMed
- Systemic therapy for patients with metastatic pheochromocytoma and paraganglioma.Alessa Fischer, Jaydira Del Rivero, Katharina Wang, Svenja Nölting, Camilo Jimenez
Best Practice & Research. Clinical Endocrinology & Metabolism. 2025-01-01 - 1 citationsEfficacy and Safety of Selective RET Inhibitors in Patients with Advanced Hereditary Medullary Thyroid Carcinoma.Sarah Hamidi, Sireesha Yedururi, Mimi I Hu, Naifa L Busaidy, Steven I Sherman
Thyroid. 2025-01-01 - International consensus statement on the diagnosis and management of phaeochromocytoma and paraganglioma in children and adolescents.Ruth T Casey, Emile Hendriks, Cheri Deal, Steven G Waguespack, Verena Wiegering
Nature Reviews. Endocrinology. 2024-12-01
Lectures
- Pheochromocytoma and Paraganglioma: Perioperative, Management, Surveillance, and New Imaging Modalities (Repeat)ENDO 2019 - New Orleans, LA - 3/23/2019
- Clinical Management of Adrenocortical CarcinomaENDO 2019 - New Orleans, LA - 3/24/2019
- Adrenal Tumors and HyperplasiaENDO 2019 - New Orleans, LA - 3/24/2019
- Join now to see all
Press Mentions
- Lantheus Announces Presentation Featuring AZEDRA® (Iobenguane I 131) at ENDO 2021March 22nd, 2021
MD Anderson Research Highlights for April 24, 2024April 25th, 2024- Cabozantinib Promising for Metastatic Pheochromocytomas, ParagangliomasApril 30th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
